hypodiploid

Hypodiploidy is a genetic term describing a chromosome complement that is lower than the normal haploid or diploid set. In humans, a haploid genome consists of 23 chromosomes, so hypodiploidy can refer to cells containing fewer than 23 chromosomes. In the context of cancer, hypodiploidy denotes tumor cells with fewer than the typical diploid (46) chromosome complement. Hypodiploidy is a form of aneuploidy and arises by loss of chromosomes during cell division, often through complex chromosomal rearrangements.

In constitutional (germline) contexts, hypodiploidy is typically associated with severe developmental consequences and is uncommon. In oncology, hypodiploidy is frequently linked with distinct tumor biology and generally correlates with a poorer prognosis compared with diploid or hyperdiploid cancers, although the impact varies by cancer type. Subtypes such as near-haploid and low-hypodiploid have been described in pediatric cancers, most notably neuroblastoma and acute lymphoblastic leukemia, and they define clinically relevant entities with characteristic chromosome losses.

Diagnosis relies on cytogenetic or genomic analyses that determine chromosome number and structure. Conventional karyotyping, fluorescence in situ hybridization, and array-based copy-number or sequencing approaches are used to identify hypodiploidy and its specific patterns of chromosomal loss.

Understanding hypodiploidy helps in prognosis, risk assessment, and, in some cancers, treatment planning, reflecting the importance of precise chromosomal characterization in oncology and human genetics.